메뉴 건너뛰기




Volumn 42, Issue 2, 2003, Pages 93-99

Vaccine interchangeability

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; IPOL; PEDIARIX; PENTACEL; POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG; VACCINE;

EID: 0037336047     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280304200201     Document Type: Review
Times cited : (13)

References (33)
  • 1
    • 0347923142 scopus 로고    scopus 로고
    • General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP)
    • Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). MMWR. 2002;51(RR-2).
    • (2002) MMWR , vol.51 , Issue.RR-2
  • 2
    • 0035158981 scopus 로고    scopus 로고
    • Interchangeability of vaccines
    • Feldman S. Interchangeability of vaccines. Pediatr Infect Dis J. 2001;20:S23-S29.
    • (2001) Pediatr Infect Dis J , vol.20
    • Feldman, S.1
  • 3
    • 0000061864 scopus 로고    scopus 로고
    • Pertussis vaccine
    • Plotkin SA, Orenstein WA, eds. Philadelphia, PA: WB Saunders
    • Edwards KM, Decker MD, Mortimer EA Jr. Pertussis vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, PA: WB Saunders; 1999:293-344.
    • (1999) Vaccines. 3rd Ed. , pp. 293-344
    • Edwards, K.M.1    Decker, M.D.2    Mortimer E.A., Jr.3
  • 4
    • 0346031563 scopus 로고    scopus 로고
    • Toronto, Ontario, Canada: Aventis Pasteur Ltd
    • Daptacel prescribing information. Toronto, Ontario, Canada: Aventis Pasteur Ltd; 2002.
    • (2002) Daptacel Prescribing Information
  • 6
    • 0004320447 scopus 로고    scopus 로고
    • Swiftwater, PA: Aventis Pasteur Inc
    • Tripedia prescribing information. Swiftwater, PA: Aventis Pasteur Inc; 2000.
    • (2000) Tripedia Prescribing Information
  • 7
    • 13344286322 scopus 로고    scopus 로고
    • A controlled-trial of two acellular vaccines and one whole-cell vaccine against pertussis
    • Greco D, Salmaso S, Mastrantonio P, et al, and the Progetto Pertosse Working Group. A controlled-trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med. 1996;334:341-348.
    • (1996) N Engl J Med , vol.334 , pp. 341-348
    • Greco, D.1    Salmaso, S.2    Mastrantonio, P.3
  • 8
    • 0030696639 scopus 로고    scopus 로고
    • Efficacy of a two-component acellular pertussis vaccine in infants
    • Liese JG, Meschievitz CK, Harzer E, et al, and the Munich Pertussis Study Group. Efficacy of a two-component acellular pertussis vaccine in infants. Pediatr Infect Dis J. 1997;16:1038-1044.
    • (1997) Pediatr Infect Dis J , vol.16 , pp. 1038-1044
    • Liese, J.G.1    Meschievitz, C.K.2    Harzer, E.3
  • 9
    • 13344295089 scopus 로고    scopus 로고
    • Efficacy of acellular pertussis vaccine in early childhood after household exposure
    • Schmitt H-J, Wirsing von König CH, Neiss A, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA. 1996;275:37-41.
    • (1996) JAMA , vol.275 , pp. 37-41
    • Schmitt, H.-J.1    Wirsing von König, C.H.2    Neiss, A.3
  • 10
    • 0032374233 scopus 로고    scopus 로고
    • A search for serologic correlates of immunity to Bordetella pertussis cough illness
    • Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illness. Vaccine. 1998;16:1901-1906.
    • (1998) Vaccine , vol.16 , pp. 1901-1906
    • Cherry, J.D.1    Gornbein, J.2    Heininger, U.3    Stehr, K.4
  • 11
    • 0032374254 scopus 로고    scopus 로고
    • Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
    • Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 1998;16:1907-1916.
    • (1998) Vaccine , vol.16 , pp. 1907-1916
    • Storsaeter, J.1    Hallander, H.O.2    Gustafsson, L.3    Olin, P.4
  • 12
    • 0035478306 scopus 로고    scopus 로고
    • Mass vaccination of children with pertussis toxoid: Decreased incidence in both vaccinated and nonvaccinated persons
    • Taranger J, Trollfors B, Bergfors E, et al. Mass vaccination of children with pertussis toxoid: Decreased incidence in both vaccinated and nonvaccinated persons. Clin Infect Dis. 2001;33:1004-1009.
    • (2001) Clin Infect Dis , vol.33 , pp. 1004-1009
    • Taranger, J.1    Trollfors, B.2    Bergfors, E.3
  • 13
    • 0036217965 scopus 로고    scopus 로고
    • Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy
    • Greenberg DP, Pickering LK, Senders SD, et al. Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy. Pediatrics. 2002;109:666-672.
    • (2002) Pediatrics , vol.109 , pp. 666-672
    • Greenberg, D.P.1    Pickering, L.K.2    Senders, S.D.3
  • 15
    • 33748557849 scopus 로고    scopus 로고
    • Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children
    • Pichichero ME, Edwards KM, Anderson EL, et al. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics. 2000;105:1-8.
    • (2000) Pediatrics , vol.105 , pp. 1-8
    • Pichichero, M.E.1    Edwards, K.M.2    Anderson, E.L.3
  • 16
    • 0030734578 scopus 로고    scopus 로고
    • A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children
    • Pichichero ME, Deloria MA, Rennels MB, et al. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children. Pediatrics. 1997;100:772-788.
    • (1997) Pediatrics , vol.100 , pp. 772-788
    • Pichichero, M.E.1    Deloria, M.A.2    Rennels, M.B.3
  • 17
    • 0002971628 scopus 로고    scopus 로고
    • Hepatitis B vaccine
    • Plotkin SA, Orenstein WA, eds. Philadelphia, PA: WB Saunders
    • Mahoney FJ, Kane M. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, PA: WB Saunders; 1999:158-182.
    • (1999) Vaccines. 3rd Ed. , pp. 158-182
    • Mahoney, F.J.1    Kane, M.2
  • 18
    • 0032868852 scopus 로고    scopus 로고
    • Antibody responses of healthy neonates to two mixed regimens of hepatitis B vaccine
    • Seto D, West DJ, Gilliam RR, et al. Antibody responses of healthy neonates to two mixed regimens of hepatitis B vaccine. Pediatr Infect Dis J. 1999;18:840-842.
    • (1999) Pediatr Infect Dis J , vol.18 , pp. 840-842
    • Seto, D.1    West, D.J.2    Gilliam, R.R.3
  • 19
    • 0025936647 scopus 로고
    • Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another
    • Bush LM, Moonsammy GI, Boscia JA. Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another. Vaccine. 1991;9:807-809.
    • (1991) Vaccine , vol.9 , pp. 807-809
    • Bush, L.M.1    Moonsammy, G.I.2    Boscia, J.A.3
  • 21
    • 0006551285 scopus 로고    scopus 로고
    • Combination vaccines for childhood immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP)
    • Centers for Disease Control and Prevention. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). MMWR. 1999;48(RR-5).
    • (1999) MMWR , vol.48 , Issue.RR-5
  • 22
    • 0032754481 scopus 로고    scopus 로고
    • Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization
    • American Academy of Pediatrics Committee on Infectious Diseases. Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization. Pediatrics. 1999;104:1404-1406.
    • (1999) Pediatrics , vol.104 , pp. 1404-1406
  • 23
    • 0034695265 scopus 로고    scopus 로고
    • Notice to readers: Recommended childhood immunization schedule - United States, 2000
    • Centers for Disease Control and Prevention. Notice to readers: recommended childhood immunization schedule - United States, 2000. MMWR. 2000;49:35-38,47.
    • (2000) MMWR , vol.49 , pp. 35-38
  • 24
    • 0025203093 scopus 로고
    • Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: Systemic and local immune responses
    • Faden H, Modlin JF, Thoms ML, et al. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis. 1990;162:1291-1297.
    • (1990) J Infect Dis , vol.162 , pp. 1291-1297
    • Faden, H.1    Modlin, J.F.2    Thoms, M.L.3
  • 25
    • 0023766078 scopus 로고
    • Serologic response to oral polio vaccine and enhancedpotency inactivated polio vaccines
    • McBean AM, Thoms ML, Albrecht P, et al, and the Field Staff and Coordinating Committee. Serologic response to oral polio vaccine and enhancedpotency inactivated polio vaccines. Am J Epidemiol. 1988;128:615-628.
    • (1988) Am J Epidemiol , vol.128 , pp. 615-628
    • McBean, A.M.1    Thoms, M.L.2    Albrecht, P.3
  • 26
    • 16944367385 scopus 로고    scopus 로고
    • Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules
    • Modlin JF, Halsey NA, Thoms ML, et al, and the Baltimore Area Polio Vaccine Study Group. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. J Infect Dis. 1997;175(suppl 1):S228-S234.
    • (1997) J Infect Dis , vol.175 , Issue.SUPPL. 1
    • Modlin, J.F.1    Halsey, N.A.2    Thoms, M.L.3
  • 27
    • 0006578115 scopus 로고    scopus 로고
    • Lyons, France: Aventis Pasteur SA
    • IPOL prescribing information. Lyons, France: Aventis Pasteur SA; 1999.
    • (1999) IPOL Prescribing Information
  • 28
    • 0034796167 scopus 로고    scopus 로고
    • Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B, and polio combination vaccine in infants
    • Yeh SH, Ward JI, Partridge S, et al. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B, and polio combination vaccine in infants. Pediatr Infect Dis J. 2001;20:973-980.
    • (2001) Pediatr Infect Dis J , vol.20 , pp. 973-980
    • Yeh, S.H.1    Ward, J.I.2    Partridge, S.3
  • 29
    • 0036551217 scopus 로고    scopus 로고
    • Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants
    • Zepp F, Schiund A, Meyer C, et al. Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants. Pediatrics. 2002;109:e58.
    • (2002) Pediatrics , vol.109
    • Zepp, F.1    Schiund, A.2    Meyer, C.3
  • 30
    • 0031970129 scopus 로고    scopus 로고
    • Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-monthold Chilean infants
    • Lagos R, Kotloff K, Hoffenbach A, et al. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-monthold Chilean infants. Pediatr Infect Dis J. 1998;17:294-304.
    • (1998) Pediatr Infect Dis J , vol.17 , pp. 294-304
    • Lagos, R.1    Kotloff, K.2    Hoffenbach, A.3
  • 31
    • 0028816708 scopus 로고
    • Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines
    • Greenberg DP, Lieberman JM, Marcy M, et al. Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines. J Pediatr. 1995;126:206-211.
    • (1995) J Pediatr , vol.126 , pp. 206-211
    • Greenberg, D.P.1    Lieberman, J.M.2    Marcy, M.3
  • 32
    • 0028920680 scopus 로고
    • Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants
    • Anderson EL, Decker MD, Englund JA, et al. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. JAMA. 1995;273:849-853.
    • (1995) JAMA , vol.273 , pp. 849-853
    • Anderson, E.L.1    Decker, M.D.2    Englund, J.A.3
  • 33
    • 0029926681 scopus 로고    scopus 로고
    • Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants
    • Goldblatt D, Fairley CK, Cartwright K, Miller E. Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants. BMJ. 1996;312:817-818.
    • (1996) BMJ , vol.312 , pp. 817-818
    • Goldblatt, D.1    Fairley, C.K.2    Cartwright, K.3    Miller, E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.